233
IMPLICATION OF HYPUSINATION IN HELICOBACTER PYLORI-INDUCED GASTRIC CARCINOGENESIS
Date
May 18, 2024
Tracks
Related Products
IL-17 SIGNALING REDUCES GASTRIC CARCINOGENESIS BY ALTERING FUNCTION OF THE HELICOBACTER CAG TYPE 4 SECRETION SYSTEM AND SUPPRESSING LRIG1 ACTIVATION
_Helicobacter pylori_ is the strongest risk factor for gastric cancer; however, only a minority of infected individuals develop disease. One microbial cancer-linked locus is the _cag_ type 4 secretion system (_cag_T4SS), which translocates the oncoprotein CagA into host cells…
EVALUATION OF THE SAFETY AND EFFICACY OF EFLORNITHINE (DIFLUOROMETHYLORNITHINE, DFMO) IN PATIENTS WITH GASTRIC PREMALIGNANT CONDITIONS IN THE HIGH INCIDENCE AREAS OF LATIN AMERICA
BACKGROUND. Gastric adenocarcinoma (GAC) is the third leading global cause of cancer mortality and the leading infection-associated cancer. In the U.S., GAC represents a major cancer disparity, with incidence rates 2-3X in non-white populations…
SPERMINE OXIDASE MEDIATES <i>HELICOBACTER PYLORI</i>-INDUCED GASTRIC CARCINOGENESIS
BACKGROUND: Tools predicting incident esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA) that can be automated in electronic health records (EHRs) to guide screening decisions are needed…
IL-17 SUPPRESSES PATHOGENESIS AND STEM CELL ACTIVATION WITHIN THE CONTEXT OF CHRONIC <i>HELICOBACTER PYLORI</i> INFECTION
BACKGROUND: Perianal fistulae are highly morbid complications of Crohn’s disease (CD) with a cumulative incidence of 20-25%; despite demonstrated efficacy of infliximab treatment, estimates of complete resolution are only 20-30%. Ultimately, 20% of patients will require proctectomy…